---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-002126"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2023-01-23T23:59:59+00:00"
generated_at: "2026-06-20T11:36:54.545564+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TRxADE HEALTH agrees to sell Alliance Pharma and CSP to Wood Sage for up to $491k

## Summary
- Sell 100% of Alliance Pharma Solutions for $125,000 and Community Specialty Pharmacy for $100,000, plus ~$266,000 under Master Service Agreement.
- Closing expected April 30, 2023, subject to Wood Sage obtaining sufficient financing.
- Divestiture of unprofitable B2C operations; company to focus on B2B marketplace.
- Sale follows evaluation of strategic alternatives begun in Q3 2022.

## SEC filing metadata
- accession: 0001493152-23-002126
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2023-01-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315223002126/0001493152-23-002126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315223002126/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-002126
- JSON: https://secwatch.observer/filing/0001493152-23-002126.json
- Plain text: https://secwatch.observer/filing/0001493152-23-002126.txt

## Key facts
- Material Agreements
  Scienture Holdings, Inc. entered into Membership Interest Purchase Agreements (Alliance Sale Agreement and CSP Sale Agreement) with Wood Sage, LLC valued at Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste (effective 2023-01-20).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Wood Sage, LLC
  - Value: Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste
  - Effective: 2023-01-20
  source text: On January 20, 2023, TRxADE HEALTH, Inc. (the “ Company ”, “ we ”, or “ us ”), entered into: (1) a Membership Interest Purchase Agreement with Wood Sage, LLC (“ Wood Sage ”), and the Company’s wholly-owned subsidiary, Alliance Pharma Solutions, LLC (“ Alliance ” and the “ Alliance Sale Agreement ”); and (2) a Membership Interest Purchase Agreement with Wood Sage and the Company’s wholly-owned subsidiary, Community Specialty Pharmacy, LLC (“ CSP ” and the “ CSP Sale Agreement ”, and together with the Alliance Sale Agreement, the “ Sale Agreements ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315223002126/0001493152-23-002126-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.